You just read:

Cannabis Science, Inc. (CBIS) Signs Drug Development and Laboratory Services Agreement with ImmunoClin Corporation (IMCL); Collaboration to Advance Clinical Studies and Formulations of the Company's Proprietary Cannabinoid Based Products

News provided by

Cannabis Science, Inc.

29 Sep, 2014, 19:17 BST